MafG accelerates cell proliferation and inhibits cell apoptosis in lung adenocarcinoma [42], while MafF promotes tumor invasion through heterodimerizing with Bach1 and activating the IL11/STAT3 pathway in breast cancer [43]. Here, BACH1 is linked to lung adenocarcinoma.